Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05997381 · ClinicalTrials.gov registry record · NA

BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears

A NA study of Rotator Cuff Tears, sponsored by CONMED Corporation.

Recruiting
Registry status
NA
Development phase
268
Enrollment target
1
Study location

NCT05997381 is a NA study of Rotator Cuff Tears that is actively recruiting participants, run by CONMED Corporation. The registered enrollment target is 268 participants, below the 1,268-participant average among 20 other Rotator Cuff Tears trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05997381, a NA study of Rotator Cuff Tears, is actively recruiting participants, sponsored by CONMED Corporation.

RECRUITING
Registry status
NA
Development phase
268 participants
Enrollment target
1
Study location

Study Summary

This study aims to evaluate the safety and effectiveness of arthroscopic rotator cuff repair augmented with the BioBrace® Implant vs. arthroscopic rotator cuff repair alone in subjects requiring surgical intervention for a full-thickness rotator cuff tear.

Conditions Studied

Interventions

  • DEVICE Arthroscopic rotator cuff repair with BioBrace® Implant augmentation.
  • PROCEDURE Arthroscopic rotator cuff repair

Study Locations (1)

Connecticut

  • ConMed - New Haven

Trial Details

FieldValue
Enrollment Target 268 participants
Start Date 2024-01-05
Est. Completion 2027-06
Phase NA

Sponsor

CONMED Corporation

2 total trials

What the Registry Record Tells You About NCT05997381

The ClinicalTrials.gov registry entry for NCT05997381 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 268 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,268-participant average among 20 other Rotator Cuff Tears trials with a reported enrollment target (79% lower). The listed sponsor is CONMED Corporation, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rotator Cuff Tears appearing as the primary indexed condition, and to 2 interventions - of which Arthroscopic rotator cuff repair with BioBrace® Implant augmentation. is the first listed.

NCT05997381 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT05997381 about?

NCT05997381 is a clinical study titled "BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears". This study aims to evaluate the safety and effectiveness of arthroscopic rotator cuff repair augmented with the BioBrace® Implant vs. arthroscopic rotator cuff repair alone in subjects requiring surgical intervention for a full-thickness rotator cuff tear.

What is the current status of trial NCT05997381?

This trial is currently recruiting. It is a NA study. The enrollment target is 268 participants. The study started on 2024-01-05. Estimated completion is 2027-06.

What conditions does trial NCT05997381 study?

This clinical trial studies the following conditions: Rotator Cuff Tears.

What interventions are being tested in trial NCT05997381?

The interventions under investigation include: Arthroscopic rotator cuff repair with BioBrace® Implant augmentation. (DEVICE), Arthroscopic rotator cuff repair (PROCEDURE).

Who is sponsoring clinical trial NCT05997381?

This trial is sponsored by CONMED Corporation, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05997381 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rotator Cuff Tears

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.